Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research.

November 30, 2018
Case Report

More haste, less speed: hyponatraemia and osmotic demyelination

Lancet
Purav ShahAli Ataya
October 18, 2018
Case Report
Open Access

Globoid cell leukodystrophy (Krabbe disease) in a Merino sheep

Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc
Effie LeeJohn Finnie
May 18, 2020
Case Report

Pontine Neoplasm or Myelinolysis Despite Normal Sodium Levels

World Neurosurgery
Lukas Andereggen, Luca Remonda
February 16, 2019
Case Report
Open Access

Osmotic Demyelination Syndrome - Evolution of Extrapontine Before Pontine Myelinolysis on Magnetic Resonance Imaging

Journal of Neurosciences in Rural Practice
Prerna GargSanjay Dhall
April 6, 2019

The role of the interdisciplinary team in subacute rehabilitation for central pontine myelinolysis

Disability and Rehabilitation
Katelyn FullerMarie Yeseta
February 26, 2019
Case Report
Open Access

Extrapontine Myelinolysis following Extreme Hypernatremia and Hyperosmolarity

Case Reports in Pediatrics
Jan-Niclas SchwadeMatthias Endmann
March 5, 2020

Neurological Complications in Recipients after Living Donor Liver Transplantation

Neurology India
Mohamed KhalilSandra Ahmed
May 26, 2020

Anesthetic Fluid Management of Patients With Hyponatremia Undergoing Living Donor Liver Transplantation

Transplantation Proceedings
Chih-Hsien WangShao-Yun Hou
June 4, 2020

Electrolyte Disorders and the Nervous System

Continuum : Lifelong Learning in Neurology
Nuri Jacoby
September 14, 2018
Case Report
Open Access

Extrapontine myelinolysis effects in intracranial langerhans cell histiocytosis: Case report

ENeurologicalSci
Rachel FormanSayona John
April 28, 2019
Case Report
Open Access

Acute parkinsonism as an unexpected consequence of pituitary adenoma resection: A case report

Medicine
Pei-Lin HoPoyin Huang
November 27, 2018
Case Report
Open Access

Brain invasion by chronic lymphocytic leukemia

Neuropathology : Official Journal of the Japanese Society of Neuropathology
Ryohei OtaniKeisuke Ueki
November 7, 2018

Extrapontine Myelinolysis and Microhemorrhages: Rare Finding in Pediatric Diabetic Ketoacidosis

Pediatric Neurology
Katherine BlineNicole O'Brien
August 2, 2019
Open Access

Severe hypokalaemia in diabetic ketoacidosis: a contributor to central pontine myelinolysis?

Endocrinology, Diabetes & Metabolism Case Reports
A ChinoyR Padidela
January 25, 2020
Open Access

MRI Patterns of Extrapontine Lesion Extension in Diffuse Intrinsic Pontine Gliomas

AJNR. American Journal of Neuroradiology
L MakepeaceZ Patay
January 1, 2020
Case Report
Open Access

Spindle Coma in the Intensive Care Unit: Different Aetiologies - Different Outcomes

European Journal of Case Reports in Internal Medicine
Ana Catarina EmidioCarlos Meneses-Oliveira
December 5, 2018
Case Report
Open Access

An autopsy case of progressive multifocal leukoencephalopathy after rituximab therapy for malignant lymphoma

Neuropathology : Official Journal of the Japanese Society of Neuropathology
Reiji MutoKoichi Ohshima
June 7, 2020

A rare case of pontine and extrapontine myelinolysis in a pediatric patient with chronic renal failure

Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery
Esra SarigeciliBurcak Cakir Pekoz
May 24, 2019
Open Access

Real-World Effectiveness and Tolerability of Tolvaptan in Patients With Heart Failure - Final Results of the Samsca Post-Marketing Surveillance in Heart Failure (SMILE) Study

Circulation Journal : Official Journal of the Japanese Circulation Society
Koichiro KinugawaYasuhiko Fukuta
September 14, 2019
Case Report
Open Access

Idiopathic Central Pontine and Extrapontine Myelinolysis in a Child

Journal of Pediatric Neurosciences
Madhav Kamath, Sneha Manjunath

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

© 2020 Meta ULC. All rights reserved
/feed-previews/central-pontine-myelinolysis/78c640ef-7db7-4612-89ec-8ba1b1d3c857